Abdominal distention

1. Liraglutide is associated with abdominal distention in humans (ROR 1.46, 95% CI 1.12-1.91).

   “Liraglutide demonstrated signals for more severe gastrointestinal AEs, including abdominal distention in type 2 diabetes (ROR = 1.46, 95% CI = 1.12-1.91)”

   HumansType 2 diabetes reports; reporting odds, not incidence

   Indication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis

   Frontiers in pharmacology·29 Sep 2026

More on Liraglutide